Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Gamida Cell Ltd.

Gamida Cell is developing expanded stem cell therapies for the treatment of such illnesses as blood cancers, cardiac disease and diabetes. The Company is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regeneration power of an ample body of therapeutic stem cells


Contact Details:
PO Box 34670
Jerusalem
91340
Israel
Tel:972-54-536-5220
Fax:
Email:marjie@gamida-cell.com
WWW:

www.GAMIDA-CELL.COM/




Recent Publications by Gamida Cell Ltd.:

Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
BACKGROUND: The Prostate Cancer Prevention Trial (PCPT) demonstrated a...
29th September, 2007
Gamida Cell Ltd, Cell Therapy Technologies, Jerusalem, Israel. J Natl Cancer Inst. 2007 Sep 19;99(18):1366-74. Epub 2007 Sep 11.
DOI Direct Link
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
BACKGROUND: We have previously demonstrated that the copper chelator...
17th February, 2006
Gamida-Cell Ltd, Jerusalem, Israel. Cytotherapy. 2004;6(4):344-55.
DOI Direct Link
Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells.
OBJECTIVES: We have demonstrated epigenetic modulation of CD34(+) cell...
13th December, 2005
Gamida Exp Hematol. 2005 Oct;33(10):1092-100.
DOI Direct Link
Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice.
OBJECTIVE: We previously demonstrated that cellular copper is involved in...
12th August, 2004
Gamida-Cell Ltd., Jerusalem, Israel. Exp Hematol. 2004 Jun;32(6):547-55.
DOI Direct Link

Press Releases on Gamida Cell Ltd.:

BioPortfolio Logo
Reportlinker Adds Global Stem Cell and Advanced Technologies Market 10th November, 2009 Reportlinker
-- Stem Cell Applications (regenerative medicine - neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases,
StemEx(R) Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cord Blood Symposium in Israel 2nd November, 2009 Gamida Cell LTD
HERZLIYA, Israel, November 2 /PRNewswire/ -- At a symposium today in Herzliya entitled Umbilical Cord Blood: An Alternative for Bone Marrow Transplantation in Adults, bone marrow transplantation
Gamida Cell and Cellerix Partner on Feasibility Study 21st October, 2009 Gamida Cell LTD
JERUSALEM and MADRID, October 21 /PRNewswire/ -- Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of
Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 30th September, 2009 Gamida Cell LTD
JERUSALEM, Israel, September 30 /PRNewswire/ -- Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx"
Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma 16th September, 2009 Gamida Cell LTD
DENVER, Colorado and JERUSALEM, September 16 /PRNewswire/ -- Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture announced today that Children's Hospital is enrolling

BioNews Results for Gamida Cell Ltd.:

StemEx Could Provide Bone Marrow Alternative
Pharmaceutical Technology:  Nov 3 2009 11:46AM Matching: gamida cell
StemEx(R) Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cor
Genetic Engineering News:  Nov 3 2009 8:36AM Matching: gamida cell
StemEx(R) Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cor
Financials.com:  Nov 3 2009 3:50AM Matching: gamida cell
StemEx(R) Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cor
KOTA Territory News:  Nov 3 2009 12:36PM Matching: gamida cell
StemEx(R) Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cor
KSLA:  Nov 3 2009 4:40AM Matching: gamida cell
Promote your company here: BioNewsCast - Press Release Distribution

View more Gamida Cell Ltd. news.

Gamida Cell Ltd. Patents:

US Patent No.Title
7429489 Methods of controlling proliferation and differentiation of stem and progenitor cells
7344881 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells
7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells
6962698 Methods of controlling proliferation and differentiation of stem and progenitor cells

View more Gamida Cell Ltd. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 580 times since April 2007, the link to the organisation's website has been followed 85 times

Recent Search Terms used to find this page: Gamida Cell Ltd. | Gamida Cell Ltd. | Gamida Cell Limited | gamida | Gamida Cell | Gamida Cell Ltd. | gamida | gamida | gamida cell | gamidace | .

Search for more companies in Jerusalem

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Gamida Cell Ltd.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.